HEMODYNAMIC DIFFERENCES BETWEEN CARVEDILOL AND LABETALOL IN THE CUTANEOUS CIRCULATION

被引:20
作者
RUFFOLO, RR
SAUERMELCH, CF
WILLETTE, RN
机构
[1] Division of Pharmacology, King of Prussia, 19406-0939, Pennsylvania
关键词
β-adrenoceptor blockers; carvedilol; cutaneous vasculature; labetalol; vasodilation;
D O I
10.1007/BF01409477
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of labetalol and carvedilol on local cutaneous microvascular perfusion and calculated local cutaneous microvascular resistance were investigated in anesthetized rats at submaximal doses that produced equivalent reductions in blood pressure and heart rate. Labetalol decreased cutaneous perfusion (- 25% ± 3%) without significantly affecting cutaneous vascular resistance ( - 6% ± 3%). In marked contrast, carvedilol dramatically increased cutaneous perfusion ( + 64% ± 9%) and significantly reduced cutaneous vascular resistance ( - 57% ± 3%). These results suggest that carvedilol and labetalol possess differences in the mechanisms by which they produce vasodilation in vivo. © 1990 Springer-Verlag.
引用
收藏
页码:S112 / S114
页数:3
相关论文
共 10 条
  • [1] ABSHAGEN U, 1987, J CARDIOVASC PHA S11, V10, P23
  • [2] LASER DOPPLER MEASUREMENTS OF BLOOD-FLOW IN SKIN TISSUE
    BOGGETT, D
    BLOND, J
    ROLFE, P
    [J]. JOURNAL OF BIOMEDICAL ENGINEERING, 1985, 7 (03): : 225 - 232
  • [3] VASCULAR EFFECTS OF CARVEDILOL, A NEW BETA-ADRENOCEPTOR ANTAGONIST WITH VASODILATING PROPERTIES, IN ISOLATED CANINE CORONARY-ARTERY
    HATTORI, Y
    NAKAYA, H
    ENDOU, M
    NAKAO, Y
    KANNO, M
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 (04) : 572 - 579
  • [4] NEEDLEMAN P, 1985, PHARM BASIC THERAPEU, V6, P806
  • [5] NICHOLS AJ, IN PRESS PHARMACOLOG
  • [6] RAHN KH, 1987, J CARDIOVASC PHA S11, V10, P18
  • [7] RUFFOLO RR, IN PRESS EUR J CLIN
  • [8] Sponer G., 1987, J CARDIOVASC PHA S11, V10, P42
  • [9] STREIN K, 1987, J CARDIOVASC PHARM, V9, P317
  • [10] WILLETTE RN, 1989, J VASC MED BIOL, V1, P211